Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378560

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378560

MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, Factor VIII, Erythropoietin (Epoetin Alfa, Darbepoietin Alfa, Epoetin Alfa-epbx ), Aflibercept, and Ziv-Aflibercept )), By Therapeutic Application, By Geography

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

MENA biologics & biosimilars market is estimated to be valued at US$ 502.2 Mn in 2023, and is expected to exhibit a CAGR of 4.6% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 502.2 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.60% 2030 Value Projection: US$ 689.3 Mn
Figure 1. MENA Biologics & Biosimilars Market Share (%), By Product Type, 2023
MENA Biologics & Biosimilars Market - IMG1

Biologics, or biological products, are medicines that are made from living organisms through highly complex manufacturing processes and must be handled and administered under carefully monitored conditions. Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, blood products, cytokines, growth factors, fusion proteins, insulin, interferon, and vaccines. Biologics are used to prevent, treat, or cure various diseases including cancer, chronic kidney disease, diabetes, cystic fibrosis, and autoimmune disorders. It improves health in many complex conditions including crohn's disease, ulcerative colitis, diabetes, rheumatoid arthritis, cancer, osteoporosis, psoriasis, HIV, multiple sclerosis, growth deficiencies, and others. In the ever-evolving pharmaceuticals and biotechnology, the concept of biologic localization has gained popularity. The Kingdom of Saudi Arabia, driven by its Vision 2030 framework, aspires to establish itself as a global biologics manufacturing hub.

Market Dynamics

The healthcare sector of Saudi Arabia is witnessing significant reforms, owing to increasing initiatives by governments, agreements between multinational pharmaceutical companies, and rising healthcare expenditures. Rapid reforms in the healthcare sector in Saudi Arabia by the government and multinational companies is expected to propel growth of the MENA biologics & biosimilars market. For instance, in March 2020, the Ministry of Health (MOH) of Saudi Arabia signed a memorandum of understanding with Sanofi, a pharmaceutical and healthcare company in Saudi Arabia to start localizing and transferring insulin industry technology locally in the Kingdom of Saudi Arabia and exploring the possibility of external exports to the GCC countries and the Middle East region. The memorandum included, the availability of diabetes medications in the Kingdom, and providing innovative healthcare solutions to treat and reduce diabetes complications in the Kingdom.

Key features of the study:

  • This report provides an in-depth analysis of the MENA biologics & biosimilars market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the MENA biologics & biosimilars market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer, Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Sanofi, and Amgen Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • MENA biologics & biosimilars market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the MENA biologics & biosimilars market

MENA Biologics & Biosimilars Market Detailed Segmentation:

  • By Product Type:
    • Influenza Vaccines
    • Factor VIII
    • Xyntha
    • Octanate
    • Kovaltry
    • Advate
    • Koate
    • Adynovate
    • Kogenate
    • Hemlibra
    • Elocta
    • Recombinate
    • Feiba
    • Immunate
    • Alphanate
    • Novoeight
    • Erythropoietin
    • Epoetin Alfa (Procrit, Epogen)
    • Darbepoietin Alfa (Aranesp)
    • Epoetin Alfa-epbx (Retacrit)
    • Aflibercept (EYLEA)
    • Ziv-Aflibercept (ZALTRAP)
  • By Therapeutic Application:
    • Hemophilia
    • Age-Related Macular Degeneration
    • Kidney Diseases
    • Influenza
    • Others
  • By Region/Country:
    • GULF
    • Saudi Arabia
    • UAE
    • Kuwait
    • Egypt
  • Company Profiles
    • Pfizer, Inc.
    • F. Hoffmann-La Roche Ltd
    • Takeda Pharmaceutical Company Limited
    • Regeneron Pharmaceuticals Inc.
    • Sanofi
    • Amgen Inc.
Product Code: CMI4393

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By Region/Country
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Recent Trends
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. MENA Biologics & Biosimilars Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. MENA Biologics & Biosimilars Market, By Product Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Influenza Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Factor VIII
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Xyntha
  • Octanate
  • Kovaltry
  • Advate
  • Koate
  • Adynovate
  • Kogenate
  • Hemlibra
  • Elocta
  • Recombinate
  • Feiba
  • Immunate
  • Alphanate
  • Novoeight
  • Erythropoietin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Epoetin Alfa (Procrit, Epogen)
  • Darbepoietin Alfa (Aranesp)
  • Epoetin Alfa-epbx (Retacrit)
  • Aflibercept (EYLEA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Ziv-Aflibercept (ZALTRAP)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. MENA Biologics & Biosimilars Market, By Therapeutic Application, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hemophilia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Age-Related Macular Degeneration
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Kidney Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Segment Trends

7. MENA Biologics & Biosimilars Market, By Region/Country, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Gulf
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Mn)
  • Saudi Arabia
  • UAE
  • Kuwait
  • Egypt
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth, By Therapeutic Application, 2018 -2030, (US$ Mn)

8. Competitive Landscape

  • Company Profiles
    • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • F. Hoffmann-La Roche Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Takeda Pharmaceutical Company Limited
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Regeneron Pharmaceuticals Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Sanofi
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Amgen Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Analyst's Views

9. Section

  • References
  • Research Methodology
  • About us and Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!